alreadi
known
topic
even
immunoglobulin
replac
respiratori
tract
infect
remain
commonest
clinic
featur
common
variabl
immunodefici
cvid
impair
qualiti
life
encapsul
bacteria
thought
common
pathogen
articl
add
knowledg
first
detail
descript
respiratori
exacerb
cvid
captur
day
data
virus
commonli
repres
delay
commenc
antibiot
therapi
respons
antibiot
therapi
depend
symptomat
present
studi
impact
current
manag
guidelin
viral
infect
common
cvid
antibiot
therapi
consid
caution
howev
selfadminist
antibiot
therapi
start
promptli
symptom
cough
purul
sputum
background
patient
common
variabl
immunodefici
cvid
suffer
frequent
respiratori
tract
infect
despit
immunoglobulin
replac
prescrib
signific
quantiti
antibiot
clinic
microbiolog
natur
exacerb
symptomat
trigger
take
antibiot
respons
treatment
previous
investig
object
describ
natur
frequenc
treatment
clinic
cours
respiratori
tract
exacerb
patient
cvid
describ
pathogen
isol
respiratori
tract
exacerb
method
perform
prospect
diari
card
exercis
patient
cvid
recruit
primari
immunodefici
clinic
unit
kingdom
gener
day
symptom
data
collect
microbiolog
sputum
microscopi
cultur
atyp
bacteri
pcr
mycobacteri
cultur
virolog
nasopharyng
swab
multiplex
pcr
sampl
symptomat
patient
cvid
result
symptomat
exacerb
exacerb
treat
antibiot
strongest
symptomat
predictor
commenc
antibiot
cough
short
breath
purul
sputum
median
delay
day
onset
symptom
commenc
antibiot
episod
character
purul
sputum
respond
quickli
antibiot
wherea
sore
throat
upper
respiratori
tract
symptom
respond
less
quickli
pathogen
viru
isol
respiratori
exacerb
potenti
pathogen
bacteria
conclus
patient
cvid
delay
avoid
treatment
symptomat
respiratori
exacerb
could
result
structur
lung
damag
howev
virus
commonli
repres
ill
domin
upper
respiratori
tract
symptom
respond
poorli
antibiot
suggest
antibiot
usag
could
better
target
common
variabl
immunodefici
cvid
heterogen
primari
immunodefici
patient
fail
produc
adequ
level
immunoglobulin
preval
abbrevi
use
copdchron
obstruct
pulmonari
diseas
cvidcommon
variabl
immunodefici
hrhazard
ratio
iqrinterquartil
rang
oator
antibiot
therapi
orodd
ratio
sgrqst
georg
respiratori
questionnair
tetreat
exacerb
tsetreat
symptomat
exacerb
useuntr
symptomat
exacerb
common
symptomat
primari
immunodefici
despit
adequ
immunoglobulin
replac
recurr
respiratori
tract
infect
commonest
clinic
featur
cvid
result
progress
bronchiectasi
respiratori
tract
infect
thought
caus
larg
encapsul
bacteria
howev
recent
evid
show
may
signific
contribut
viral
infect
despit
high
incid
respiratori
tract
infect
neg
influenc
qualiti
life
primari
antibodi
defici
syndrom
natur
symptom
episod
remain
unknown
patient
often
prescrib
antibiot
mitig
respiratori
tract
infect
rescu
cours
promptli
selfadminist
acut
event
prophylaxi
reduc
infect
frequenc
howev
symptomat
trigger
take
breakthrough
antibiot
clinic
respons
treatment
known
prospect
studi
sought
answer
question
systemat
record
daili
symptom
treatment
cohort
patient
cvid
winter
period
parallel
analysi
also
explor
bacteri
viral
pathogen
encount
acut
respiratori
symptom
patient
cvid
patient
recruit
joint
immunologyrespiratori
servic
royal
free
hospit
london
patient
diagnosi
cvid
made
clinic
immunologist
follow
definit
panamerican
group
immunodefici
european
societi
immunodefici
receiv
immunoglobulin
replac
regular
least
clinic
review
exclus
criterion
inabl
provid
inform
consent
particip
provid
written
inform
consent
rec
observ
prospect
cohort
studi
patient
complet
daili
checkbox
symptom
diari
day
decemb
februari
cover
uk
winter
season
particip
ask
report
new
increas
respiratori
symptom
predefin
list
tabl
chronic
stabl
symptom
report
definit
symptom
instruct
diari
complet
clearli
explain
detail
provid
articl
onlin
repositori
wwwjaciinpracticeorg
previous
use
methodolog
chronic
respiratori
diseas
particip
patient
also
ask
complet
st
georg
respiratori
questionnair
sgrq
valid
measur
respiratori
health
statu
score
best
worst
qualiti
life
simultan
independ
describ
studi
conduct
crosssect
studi
patient
experienc
acut
respiratori
symptom
provid
sampl
nasopharyng
swab
spontan
expector
sputum
bacteri
viral
test
sputum
consid
purul
granulocyt
per
hpf
found
sampl
either
collect
clinic
staff
care
instruct
sampl
submit
directli
patient
mail
figur
show
investig
undertaken
cohort
preanalysi
group
clinic
relat
symptom
present
tabl
calcul
total
symptom
count
symptom
count
individu
patient
day
cumul
total
symptom
count
sum
day
exacerb
period
use
definit
exacerb
base
either
symptom
health
care
util
similar
methodolog
report
valid
chronic
obstruct
pulmonari
diseas
copd
first
definit
identifi
symptomat
exacerb
event
new
symptom
last
consecut
day
record
patient
diari
whether
receiv
addit
treatment
start
symptomat
exacerb
episod
first
day
new
symptom
last
consecut
day
end
episod
last
consecut
day
symptom
allow
symptom
chang
time
oral
antibiot
therapi
oat
use
symptomat
exacerb
episod
consid
treat
symptomat
exacerb
tse
untreat
symptomat
exacerb
use
defin
health
care
util
exacerb
use
oat
worsen
respiratori
symptom
call
treat
exacerb
te
event
coincid
diarydefin
symptom
would
tse
episod
consid
last
first
day
symptom
occur
recoveri
defin
last
day
symptom
present
oat
start
addit
detail
regard
exacerb
variabl
statist
analysi
perform
use
stata
version
statacorp
lp
colleg
station
tex
continu
variabl
present
median
first
third
quartil
mean
sd
appropri
categor
binari
variabl
present
frequenc
miss
data
imput
result
consid
statist
signific
p
valu
less
data
analyz
logist
regress
trigger
symptom
analysi
cox
regress
antibiot
respons
analysi
pearson
correl
wilcoxon
rank
sum
test
test
indic
detail
provid
articl
onlin
repositori
wwwjaciinpracticeorg
multiplex
realtim
pcr
rtpcr
adenoviru
coronaviru
hku
enteroviru
human
metapneumoviru
influenza
viru
b
parainfluenza
viru
parechoviru
respiratori
syncyti
viru
rhinoviru
perform
nation
health
servic
virolog
laboratori
royal
free
hospit
sputum
sampl
examin
microscopi
cultur
bacteria
mycobacteria
plu
inhous
multiplex
rtpcr
chlamydia
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
detail
provid
articl
onlin
repositori
wwwjaciinpracticeorg
includ
multipl
sampl
singl
patient
separ
least
week
patient
asymptomat
episod
airway
colon
pathogen
bacteria
diagnos
organ
isol
twice
within
year
studi
total
patient
cvid
given
diari
patient
return
diari
complet
studi
period
provid
day
data
figur
demograph
clinic
characterist
includ
patient
present
tabl
ii
patient
complet
diari
older
p
studi
period
symptomat
exacerb
event
mean
per
patient
month
event
mean
per
patient
month
treat
oat
mean
per
patient
month
nine
patient
symptomat
exacerb
period
publish
literatur
suggest
cours
antibiot
prescrib
per
men
per
women
respiratori
tract
infect
gener
practition
unit
kingdom
correspond
cours
antibiot
total
per
patient
month
prescrib
group
similar
cohort
gener
popul
month
tse
episod
sever
use
term
cumul
total
symptom
count
median
iqr
vs
symptom
p
episod
durat
median
durat
vs
day
hazard
ratio
hr
p
total
te
cover
within
studi
period
one
te
meet
criteria
tse
median
iqr
durat
te
episod
day
median
iqr
time
start
symptom
oat
day
median
iqr
time
recoveri
day
median
iqr
durat
therapi
day
detail
descript
symptom
preval
shown
figur
treatment
patient
use
coamoxiclav
exacerb
amoxicillin
exacerb
doxycyclin
exacerb
ciprofloxacin
exacerb
clarithromycin
exacerb
azithromycin
erythromycin
flucloxacillin
levofloxacin
exacerb
cough
short
breath
purul
sputum
strongest
trigger
patient
initi
antibiot
therapi
compar
day
oat
start
day
without
oat
day
compris
remaind
antibiot
cours
ignor
univari
analysi
symptom
posit
significantli
associ
start
oat
cough
odd
ratio
ct
xray
comput
tomographi
note
p
valu
calcul
use
wilcoxon
rank
sum
test
continu
variabl
fisher
exact
test
categor
variabl
serum
igg
level
measur
immedi
next
immunoglobulin
replac
administ
sever
index
rang
best
worst
valid
multicompon
score
bronchiectasi
predict
futur
risk
exacerb
hospit
mortal
zfev
predict
proport
actual
fev
vs
predict
fev
accord
european
respiratori
societi
guidelin
xthe
sgrq
valid
measur
respiratori
health
statu
score
best
worst
qualiti
life
univari
analysi
time
sinc
start
symptom
posit
associ
start
oat
instead
patient
start
oat
fairli
constant
rate
first
day
symptom
figur
b
howev
signific
posit
associ
total
symptom
count
start
oat
ci
suggest
approxim
doubl
odd
start
oat
addit
symptom
mean
number
symptom
day
oat
start
ae
versu
ae
symptom
day
antibiot
taken
p
exacerb
character
purul
sputum
respond
rapidli
antibiot
wherea
character
upper
respiratori
tract
symptom
sore
throat
respond
slowli
median
iqr
time
recoveri
start
oat
te
day
figur
te
time
recoveri
day
less
day
less
univari
analysi
time
recoveri
longer
presenc
upper
respiratori
tract
symptom
median
vs
day
hr
p
figur
b
sore
throat
vs
day
hr
p
figur
c
white
sputum
vs
day
hr
p
day
commenc
oat
howev
time
recoveri
shorter
exacerb
purul
sputum
present
vs
day
hr
p
figur
multivari
analysi
upper
respiratori
tract
symptom
sore
throat
purul
sputum
signific
independ
predictor
respons
oat
figur
e
statist
signific
correl
time
start
oat
time
recoveri
total
symptom
count
day
oat
start
subsequ
time
recoveri
howev
longer
time
start
oat
associ
longer
episod
durat
hr
p
patient
take
prophylact
antibiot
untreat
exacerb
wait
longer
onset
symptom
initi
breakthrough
antibiot
proceed
investig
whether
frequenc
natur
exacerb
affect
antibiot
prophylaxi
presenc
bronchiectasi
mean
number
symptomat
exacerb
total
treat
untreat
analyz
test
interact
test
prophylact
antibiot
bronchiectasi
analys
varianc
symptomat
exacerb
event
patient
prophylact
antibiot
patient
prophylaxi
higher
number
symptomat
exacerb
use
patient
prophylact
antibiot
depend
presenc
absenc
bronchiectasi
observ
mean
differ
number
symptomat
exacerb
patient
prophylaxi
bronchiectasi
without
use
differ
regard
impact
antibiot
prophylaxi
exacerb
sever
signific
differ
episod
durat
cumul
total
symptom
count
symptomat
exacerb
patient
prophylact
antibiot
patient
take
prophylact
antibiot
wait
longer
start
oat
breakthrough
infect
median
vs
e
forest
plot
display
hr
time
recoveri
start
oat
depend
presenc
specif
symptom
multivari
cox
model
use
symptom
prove
signific
univari
analysi
multivari
data
shown
variabl
hr
reflect
risk
earlier
complet
symptomat
remiss
time
isv
increas
sputum
volum
sob
short
breath
j
allergi
clin
immunol
pract
volum
number
day
hr
p
howev
time
recoveri
commenc
oat
significantli
differ
patient
prophylact
antibiot
signific
differ
patient
without
bronchiectasi
exacerb
sever
time
oat
time
recoveri
prospect
symptom
correl
modestli
crosssect
analysi
qualiti
life
moder
correl
sgrq
total
score
number
day
new
cough
r
p
sore
throat
r
p
short
breath
r
p
wheez
r
p
present
cumul
total
symptom
count
cumul
number
day
symptomat
exacerb
episod
studi
period
also
correl
sgrq
symptom
score
r
p
sgrq
total
score
r
p
total
nasopharyng
swab
obtain
patient
acut
respiratori
symptom
virus
detect
exacerb
figur
rhinoviru
common
viru
detect
exacerb
includ
coinfect
respiratori
syncyti
viru
coinfect
adenoviru
coinfect
human
metapneumoviru
total
spontan
expector
sputum
sampl
obtain
patient
acut
respiratori
symptom
pathogen
bacteria
isol
exacerb
figur
common
bacteria
haemophilu
influenza
streptococcu
pneumonia
pseudomona
aeruginosa
exacerb
two
patient
account
exacerb
colon
h
influenza
defin
earlier
sampl
neg
mycobacteri
cultur
pcr
atyp
pneumonia
organ
bacteri
viral
coinfect
exacerb
pathogen
found
microscop
evid
purul
measur
granulocyt
per
hpf
found
microscopi
exacerb
posit
pathogen
viru
whether
patient
produc
sputum
exacerb
posit
pathogen
viru
contemporan
sputum
collect
exacerb
posit
pathogen
bacteria
first
prospect
cohort
studi
describ
symptom
treatment
respiratori
tract
infect
cvid
discov
clinic
import
delay
commenc
antibiot
therapi
mani
symptom
untreat
especi
patient
take
prophylact
antibiot
episod
character
purul
sputum
respond
quickli
antibiot
wherea
sore
throat
upper
respiratori
tract
symptom
respond
less
quickli
perhap
correspondingli
mani
respiratori
exacerb
detect
pathogen
viru
patient
cvid
frequent
prescrib
antibiot
educ
promptli
take
suffer
breakthrough
infect
howev
actual
behavior
relat
therapi
previous
document
across
day
data
discov
individu
warn
symptom
cough
short
breath
purul
sputum
import
trigger
patient
start
oat
time
sinc
start
symptom
less
import
trigger
proport
patient
start
therapi
day
fairli
constant
across
first
day
symptom
consequ
despit
fact
patient
antibiot
avail
immedi
usag
median
delay
day
start
oat
investig
whether
delay
commenc
treatment
explain
patient
choic
access
health
care
longer
time
commenc
therapi
advers
impact
subsequ
respons
antibiot
measur
time
recoveri
inevit
increas
total
length
infecti
episod
infect
cvid
lead
structur
lung
damag
delay
may
clinic
signific
similarli
mani
exacerb
across
studi
period
untreat
may
report
without
prospect
data
collect
inde
well
document
use
often
go
unreport
copd
time
exacerb
collect
symptom
diari
interview
patient
copd
also
treat
half
exacerb
record
diari
respons
oat
judg
time
recoveri
correl
delay
commenc
therapi
total
symptom
count
depend
individu
symptom
slower
respons
patient
upper
respiratori
tract
symptom
sore
throat
hypothes
may
explain
pure
viral
etiolog
episod
convers
exacerb
purul
sputum
resolv
quickli
antibiot
perhap
indic
domin
bacteri
compon
number
use
delay
commenc
oat
higher
patient
prophylact
antibiot
could
impli
reluct
start
oat
group
overreli
prophylaxi
increas
toler
symptom
gener
prophylaxi
institut
patient
background
high
incid
exacerb
found
differ
sever
durat
individu
symptomat
exacerb
without
prophylaxi
could
indic
effect
prophylaxi
convers
evid
prophylaxi
attenu
sever
breakthrough
exacerb
modest
correl
acut
symptom
report
diari
sgrq
measur
impact
symptom
healthrel
qualiti
life
cumul
total
symptom
count
cumul
number
day
symptomat
exacerb
studi
period
also
correl
sgrq
score
confirm
symptomat
exacerb
signific
impact
patient
howev
studi
design
includ
new
worsen
symptom
rather
chronic
symptom
presum
explain
moder
correl
diaryderiv
paramet
sgrq
score
analysi
pathogen
isol
symptomat
exacerb
detect
viru
patient
sampl
similar
report
exampl
kainulainen
et
al
report
posit
viral
pcr
exacerb
patient
bacteri
pathogen
commonli
encapsul
organ
found
symptomat
exacerb
interestingli
exacerb
posit
pathogen
viru
patient
also
expector
sputum
evid
purul
measur
high
microscop
granulocyt
count
sampl
although
may
partli
explain
underli
bronchiectasi
patient
frequent
observ
coinfect
bacteria
although
may
repres
simpli
colon
bacteria
presenc
acut
viral
exacerb
evid
copd
rhinoviru
infect
advers
affect
microbiom
preval
pathogen
bacteria
earlier
result
suggest
new
worsen
purul
sputum
predict
rapid
respons
antibiot
therapi
regardless
organ
isol
research
requir
investig
pathogen
identifi
influenc
balanc
organ
respiratori
tract
therebi
respons
antibiot
therapi
howev
current
recommend
would
promptli
treat
exacerb
character
purul
sputum
irrespect
virolog
result
least
neutrophil
elastas
significantli
implic
bronchiectasi
pathogenesi
studi
limit
perform
singl
tertiari
care
center
winter
respiratori
tract
infect
frequent
true
incid
symptomat
exacerb
antibiot
use
throughout
year
thu
extrapol
exclud
factor
particular
geograph
locat
particular
brief
studi
period
influenc
result
pathogen
gray
found
exacerb
pathogen
viru
found
exacerb
rhinoviru
found
exacerb
includ
coinfect
adenoviru
adeno
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
b
bacteri
cultur
perform
spontan
expector
sputum
symptomat
respiratori
exacerb
patient
cvid
pathogen
gray
found
exacerb
pathogen
bacterium
found
exacerb
pseudomona
aeruginosa
isol
exacerb
among
coinfect
streptococcu
pneumonia
two
patient
account
exacerb
probabl
colon
haemophilu
influenza
j
allergi
clin
immunol
pract
volum
number
design
studi
lack
healthi
control
group
therefor
discuss
differ
qualiti
quantiti
exacerb
cvid
nonimmunocompromis
patient
avail
data
sourc
suggest
usag
antibiot
cohort
mani
time
higher
gener
popul
data
patient
agre
complet
diari
patient
entir
cvid
cohort
patient
may
result
select
bia
especi
patient
older
clinic
sever
bronchiectasi
although
exacerb
differ
number
sever
patient
without
bronchiectasi
generaliz
may
affect
variat
preval
bronchiectasi
throughout
center
symptomat
definit
respiratori
exacerb
cvid
standard
therefor
oper
simplifi
definit
valid
copd
although
patient
care
instruct
record
new
wors
symptom
exclud
possibl
report
chronic
morbid
note
mean
number
new
symptom
even
day
without
antibiot
therapi
howev
includ
period
antibiot
therapi
exacerb
may
also
reflect
genuin
high
frequenc
acut
symptom
mani
patient
resid
signific
distanc
hospit
unabl
perform
microbiolog
virolog
test
diarydefin
exacerb
thu
perform
parallel
studi
figur
demonstr
respiratori
exacerb
extrem
common
cvid
patient
delay
start
antibiot
ignor
symptom
although
virus
identifi
commonli
patient
nevertheless
educ
take
antibiot
promptli
develop
purul
sputum
observ
prospect
cohort
studi
patient
complet
daili
checkbox
symptom
diari
day
decemb
februari
particip
ask
report
new
increas
respiratori
symptom
predefin
list
figur
chronic
stabl
symptom
report
patient
report
daili
use
oat
treat
breakthrough
infect
month
use
prophylact
antibiot
patient
discontinu
prophylact
antibiot
start
oat
breakthrough
infect
particip
patient
also
ask
complet
sgrq
valid
measur
respiratori
health
statu
score
best
worst
qualiti
life
point
consid
minimum
clinic
import
differ
sgrq
conduct
end
studi
period
recal
period
cover
period
diari
compet
baselin
inform
spirometri
comput
chest
tomographi
previou
bacteri
isol
sputum
cultur
medic
research
council
breathless
score
smoke
statu
collect
medic
record
department
databas
data
calcul
bronchiectasi
sever
index
valid
multicompon
score
bronchiectasi
predict
futur
risk
exacerb
hospit
mortal
simultan
conduct
observ
crosssect
studi
patient
experienc
acut
respiratori
symptom
provid
sampl
bacteri
viral
test
total
nasopharyng
swab
collect
patient
patient
abl
toler
procedur
total
spontan
expector
sputum
sampl
obtain
patient
patient
abl
produc
suffici
quantiti
sputum
sampl
either
collect
clinic
staff
care
instruct
sampl
submit
directli
patient
mail
patient
recruit
outpati
clinic
royal
free
hospit
london
patient
diagnosi
cvid
written
inform
consent
includ
studi
patient
exclus
criteria
sent
copi
diari
instruct
patient
exampl
shown
figur
patient
decid
particip
least
followup
contact
studi
period
via
telephon
via
post
clinic
visit
provid
counsel
diari
improv
adher
total
patient
return
fulli
complet
diari
schedul
adhoc
visit
outpati
clinic
patient
cohort
consent
patient
cvid
also
ask
provid
microbiolog
sampl
time
acut
exacerb
patient
provid
sampl
preanalysi
group
clinic
relat
symptom
present
tabl
block
nose
nasal
discharg
sinu
pain
combin
upper
respiratori
tract
symptom
yellow
green
sputum
combin
purul
sputum
wherea
report
increas
sputum
volum
analyz
singl
paramet
calcul
total
symptom
count
symptom
count
individu
give
theoret
rang
total
symptom
day
purpos
analysi
exacerb
distinguish
exacerb
event
exacerb
episod
event
occurr
one
time
point
wherea
episod
time
period
defin
start
end
exacerb
event
associ
exacerb
episod
event
calcul
incid
rate
associ
paramet
time
event
episod
calcul
timedepend
characterist
durat
total
symptom
count
plot
symptom
preval
time
use
differ
definit
exacerb
figur
base
either
symptom
health
care
util
first
definit
identifi
symptomat
exacerb
event
new
symptom
last
consecut
day
record
patient
diari
whether
receiv
addit
treatment
symptomat
exacerb
event
associ
symptomat
exacerb
episod
start
symptomat
exacerb
episod
first
day
new
symptom
last
consecut
day
end
symptomat
exacerb
episod
defin
last
consecut
day
symptom
allow
symptom
chang
time
durat
episod
thu
given
time
first
day
least
symptom
occur
last
day
symptom
present
oat
use
symptomat
exacerb
episod
consid
tse
use
basi
treatment
defin
health
care
util
exacerb
use
oat
worsen
respiratori
symptom
call
te
event
coincid
diarydefin
symptom
would
tse
studi
te
fulfil
criteria
tse
analog
definit
symptomat
exacerb
episod
te
event
associ
te
episod
te
episod
last
first
day
symptom
occur
last
day
symptom
still
present
symptom
present
day
oat
start
time
oat
defin
period
first
day
symptom
occurr
first
day
oat
time
recoveri
defin
period
day
oat
start
day
symptom
end
togeth
time
oat
time
recoveri
repres
te
durat
te
partial
cover
within
studi
period
use
censor
data
time
oat
time
recoveri
statist
analysi
perform
use
stata
version
statacorp
lp
colleg
station
tex
summar
continu
variabl
median
iqr
mean
sd
appropri
categor
binari
variabl
present
frequenc
result
consid
statist
signific
p
valu
less
miss
data
imput
six
patient
diari
group
complet
sgrq
data
patient
ignor
qualityoflif
analysi
miss
data
unabl
calcul
bronchiectasi
sever
index
patient
diari
group
comput
tomographi
scan
avail
patient
diari
group
data
lung
function
miss
patient
diari
group
trigger
symptom
analysi
antibiot
respons
analysi
analyz
symptom
trigger
patient
start
antibiot
treatment
day
without
oat
first
day
start
oat
includ
analysi
day
consecut
cours
oat
ignor
first
examin
associ
symptom
separ
start
oat
calcul
or
ci
symptom
univari
analysi
next
includ
symptom
prove
signific
univari
analysi
logist
regress
model
analyz
effect
adjust
symptom
similarli
or
calcul
test
associ
total
symptom
count
time
sinc
start
symptom
start
oat
time
sinc
start
symptom
defin
number
day
symptom
present
assess
respons
oat
analyz
time
recoveri
start
oat
cumul
total
symptom
count
start
oat
cumul
total
symptom
count
sum
symptom
day
start
oat
last
day
symptom
still
present
result
use
either
paramet
similar
report
time
recoveri
analyz
predict
valu
symptom
respons
oat
separ
first
use
univari
cox
regress
model
next
use
multivari
cox
regress
model
symptom
prove
signific
predictor
univari
set
examin
effect
adjust
symptom
analyz
predict
valu
time
oat
total
symptom
count
day
start
oat
respons
oat
use
univari
cox
model
exacerb
sever
analysi
indic
exacerb
sever
use
exacerb
durat
cumul
total
symptom
count
exacerb
episod
cumul
total
symptom
count
defin
sum
symptom
durat
exacerb
episod
use
cox
model
compar
durat
wilcoxon
rank
sum
test
compar
cumul
total
symptom
count
bronchiectasi
prophylact
antibiot
analysi
analyz
impact
prophylact
antibiot
bronchiectasi
compar
patient
prophylact
antibiot
without
radiolog
evid
bronchiectasi
regard
number
exacerb
exacerb
sever
symptomat
exacerb
time
oat
time
recoveri
use
test
compar
mean
number
symptomat
exacerb
number
tse
number
use
signific
differ
differ
mean
valu
assess
interact
test
anova
time
oat
time
recoveri
episod
durat
symptomat
exacerb
compar
use
univari
cox
regress
model
qualityoflif
analysi
sgrq
valid
wide
use
measur
respiratori
health
base
recal
period
total
score
continu
variabl
rang
indic
low
indic
high
impair
respiratori
health
basi
diari
data
calcul
number
day
specif
symptom
present
entir
studi
period
day
cumul
total
symptom
count
sum
total
symptom
count
entir
studi
figur
exampl
section
symptom
diari
check
mark
indic
presenc
respect
symptom
oat
dash
indic
absenc
specif
symptom
oat
particip
record
sputum
color
absentunchang
white
w
yellow
green
g
sputum
volum
record
absentunchang
increas
equival
volum
teaspoon
ts
egg
cup
eg
cup
c
particip
ask
record
new
increas
symptom
indic
oatwa
use
indic
either
use
nonus
use
defin
event
total
symptom
count
tsc
equal
greater
consecut
day
absenc
oat
episod
tse
defin
event
total
symptom
count
equal
greater
consecut
day
use
oat
episod
te
defin
use
oat
start
te
episod
defin
first
day
symptom
occur
still
present
day
oat
start
end
te
episod
defin
last
day
symptom
present
also
present
day
oat
start
time
oat
defin
period
te
start
oat
start
time
recoveri
defin
period
oat
start
te
end
